Author | Philip A. Philip, MD, PhD


Novel Agents in Pancreatic Cancer

March 31, 2017

This video covers the latest research in pancreatic cancer, including the possible role of PARP inhibitors, immunotherapy, and the novel drug PEGPH20.

Systemic Therapy of Pancreatic Cancer: Better Science, Faster Progress

November 15, 2015

The ultimate benefit to patients will come from a demonstration of clinically worthwhile benefits of new drugs that have been tested in well-designed and adequately powered clinical trials performed in an expedited fashion.